One of the most common birth defects worldwide is hearing loss. Every 1,000 babies born worldwide are affected by permanent hearing loss in one or both ears. Hearing loss can significantly affect a baby's development.
CapitalBiotech has developed the Hereditary Deafness Gene Detection Assay using semiconductor sequencing technology. It can identify 100 mutant sites on 18 deafness-related genes such as GJB2, SLA26A4, GJB3, MT-RNR1, and others. This detection assay boasts an accuracy of over 99.9%.
The BioElectron Gene Squencer 4000 platform was developed in collaboration with Thermo Fisher. It can detect 384 samples simultaneously.
Microbiome Sequencing: The Next Frontier in Personalized MedicineJune 26, 2023In the past few decades, we have witnessed remarkable advancements in medical technology that have revolutionized the way we approach healthcare. One of the most promising frontiers in this field is m...view
Next Generation Sequencing (NGS) TechnologyApril 8, 2024Next Generation Sequencing (NGS), also known as high-throughput sequencing, revolutionized the field of genomics. Unlike traditional Sanger sequencing methods, NGS allows researchers to analyze vast a...view
A Brief Analysis of Microfluidic TechnologyApril 16, 2025What is Microfluidic TechnologyMicrofluidic technology is a scientific technology characterized by the precise manipulation of fluids in micro-nano scale spaces. It has the ability to miniaturize the ...view
16S vs 18S vs ITS SequencingMarch 7, 2024CapitalBio, a leader in microbiome research, delves into the fascinating world of microbial identification through 16S, 18S, and ITS sequencing technologies. This article explores these techniques to ...view